Star Lake Bioscience Co (SHSE:600866) LT-Debt-to-Total-Asset : 0.12 (As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Star Lake Bioscience Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Star Lake Bioscience Co's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.12.

Star Lake Bioscience Co's long-term debt to total assets ratio increased from Mar. 2023 (0.10) to Mar. 2024 (0.12). It may suggest that Star Lake Bioscience Co is progressively becoming more dependent on debt to grow their business.

Star Lake Bioscience Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Star Lake Bioscience Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Star Lake Bioscience Co LT-Debt-to-Total-Asset Chart

Star Lake Bioscience Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.01

0.06

0.05

0.10

0.12

Star Lake Bioscience Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.10	0.09	0.10	0.12	0.12

Star Lake Bioscience Co LT-Debt-to-Total-Asset Calculation

Star Lake Bioscience Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	1760.667	/	14384.586
	=	0.12

Star Lake Bioscience Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	1705.445	/	14687.215
	=	0.12

Star Lake Bioscience Co (SHSE:600866) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Star Lake Bioscience Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Star Lake Bioscience Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Star Lake Bioscience Co (SHSE:600866) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Star Lake Bioscience Co Inc (SHSE:600866) » Definitions » LT-Debt-to-Total-Asset

Traded in Other Exchanges

N/A

Address

No. 67 Gongnong North Road, Guangdong Province, Zhaoqing, CHN, 526060

Website

http://www.starlake.com.cn

Star Lake Bioscience Co Inc is a China-based Pharmaceutical manufacturer. The company is mainly engaged in the research, development, production, and sales of chemical raw materials and pharmaceutical intermediates. Products offered by the company include proline, guanosine, adenosine, adenine, adefovir dipivoxil, memantine hydrochloride, Proline, threonine, lysine, among others. Its products are used in food processing, feed processing, and pharmaceutical manufacturing. Star Lake sells its products through direct sales and distributors in China and overseas markets.

Star Lake Bioscience Co (SHSE:600866) Headlines

No Headlines